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Abstract
Background: Waist-to-height ratio (WHtR) has been reported as a prefer-
able risk related body fat (BF) marker, although no standardised waist
circumference measurement protocol (WCmp) has been proposed. The
present study aimed to investigate whether the use of a different WCmp
affects the strength of relationship between WHtR and both whole and
central BF in non-alcoholic fatty liver disease (NAFLD) patients.
Methods: BF was assessed with dual energy X-ray absorptiometry (DXA) in
28 NAFLD patients [19 males, mean (SD) 51 (13) years and nine females,
47 (13) years]. All subjects also underwent anthropometric evaluation
including height and waist circumference (WC) measurement using four
different WCmp (WC1, minimal waist; WC2, iliac crest; WC3, mid-distance
between iliac crest and lowest rib; WC4, at the umbilicus) and WHtR was
calculated using each WC measurements (WHtR1, WHtR2, WHtR3 and
WHtR4, respectively). Partial correlations were conducted to assess the rela-
tion of WHtR and DXA assessed BF.
Results: All WHtR were particularly correlated with central BF, including
abdominal BF (r = 0.80, r = 0.84, r = 0.84 and r = 0.78, respectively, for
WHtR1, WHtR2, WHtR3 and WHtR4) and central abdominal BF (r = 0.72,
r = 0.77, r = 0.76 and r = 0.71, respectively, for WHtR1, WHtR2, WHtR3
and WHtR4), after controlling for age, sex and body mass index. There were
no differences between the correlation coefficients obtained between all
studied WHtR and each whole and central BF variable.
Conclusions: Waist-to-height ratio was found a suitable BF marker in the
present sample of NAFLD patients and the strength of the relationship
between WHtR and both whole and central BF was not altered by using
different WCmp in the present sample of NAFLD patients.
Introduction
Waist-to-height ratio (WHtR) is an index of abdominal
obesity initially proposed by Hsieh and Yoshinaga in the
1990s (1,2). At that time, WHtR was suggested to be a better
predictor of multiple coronary heart disease risk factors
than other obesity and fat distribution indices in both men
(1) and women (2). Despite not being accepted consensually
(3,4), WHtR was further suggested to be preferable to other
indices and clinical assessments, including body mass
185ª 2016 The British Dietetic Association Ltd.
Journal of Human Nutrition and Dietetics
index (BMI), waist circumference (WC) and waist-to-hip
ratio (WHR), for predicting cardiovascular risk factors in
different ethnic and age groups (5,6). WHtR also appeears
to be at least similarly associated with abdominal fat as is
WC, and better than both BMI and WHR (7,8). To our
knowledge, few studies have focused on non-alcoholic fatty
liver disease (NAFLD) patients using WHtR (9,10). These
studies have found rather high WHtR in NAFLD patients
(9,10) which is concordant with the increased cardiovascular
risk found in NAFLD patients (10–14). It is therefore of
utmost important to establish standardised clinical body
composition (BC) surrogates, as well as potential therapy
targets, particularly in higher risk subpopulations, such as
patients with NAFLD.
Despite being a promising clinical marker of BC (8,15)
and related cardiometabolic risk (5), there is still some
inconsistency considering the WC measurement protocol
(WCmp) used to calculate WHtR (16). Several WCmp
have been proposed by sound authorities, and used by
prominent researchers, although scientific rational is lack-
ing to recommend one single protocol (17–19). The associa-
tion of WC with cardiometabolic risk is independent of
WCmp (19). However, measurements using different
WCmp have different magnitudes and therefore are not
interchangeable (19). Proposed protocols differ mainly on
the anatomical landmarks and correspondent measuring
sites. WHtR was initially proposed using WC measured at
the umbilicus (1,2). In subjects without diagnosed diseases
WHtR calculated using WC measured at the umbilicus
was suggested to be preferable for the estimation of both
whole and trunk body fat (BF); however, only two WC
measurement protocols were tested (narrowest point
between the lower costal border and the top of the iliac
crest and at the level of the umbilicus) (15). In a recent
review on WHtR (16), the WC as measured midpoint
between the lowest rib and iliac crest was found to be
used in 50% of the reviewed papers and, for that reason,
its routine use was encouraged.
To our knowledge, it is unknown whether the use of
different commonly used waist circumferences, with dif-
ferent measuring sites, affects the relationship between
WHtR and both whole and central BF content in NAFLD
patients. The independent magnitude of such a relation-
ship is also unknown. Therefore, the present study aimed
to determine which of the most used WCmp is better for
calculating WHtR for use in clinical practice with NAFLD
patients as a surrogate for whole and central BF.
Materials and methods
Subjects
The present study was conducted at Exercise and Health
Laboratory, from the Interdisciplinary Centre for the
Study of Human Performance (Faculty of Human Kinet-
ics, Technical University of Lisbon, Portugal). To be
selected for the study, subjects had to be aged >18 years
of age without a history of hepatotoxic substances intake
(e.g. steroids) and tobacco consumption. Exclusion crite-
ria included alcohol consumption >20 g day1; the pres-
ence of other potential causes for fatty liver disease,
including viral hepatitis, auto-immune disease and others;
any physical and/or mental disabilities or any condition
that constituted an absolute restriction to exercise; or
other diagnosed diseases, except for metabolic and cardio-
vascular disease (insulin resistance, hypertension or dys-
lipidaemia), with mandatory specific pharmacological
therapy. We studied 28 NAFLD patients [19 males, mean
(SD) 51 (13) years and nine females, 47 (13) years] who
were diagnosed via liver biopsy or ultrasound. Cardiores-
piratory fitness was assessed as described previously (20)
for characterisation purposes. Subjects were recruited
from the outpatient medical departments in Santa Maria
Hospital and Curry Cabral Hospital; 59 consecutive
patients were selected based on selection criteria; 37 of
the selected subjects accepted to participate and 28 were
found eligible to enter the study after exclusion criteria
were considered. Subjects were taking one or more of the
following medications: platelet inhibitors, angiotensin-
converting enzyme inhibitors, nitrates, statins, ezetimibe,
nicotinic acid and biguanides, with similar use among
both sexes. All participants provided their informed con-
sent before being included in the present study and
undergoing any study procedure. All methods used in the
present study complied with ethics and Portuguese laws
and were approved by Faculty of Human Kinetics institu-
tional review board for human studies
Body composition
Body composition was assessed using dual energy X-ray
absorptiometry (DXA) (Explorer W, Hologic; Waltham,
MA, USA; Fan beam mode) whole body scans and
anthropometric measurements. Repeated measurements
with DXA in 18 young adults showed a coefficient of
variation (CV) of 1.7% for total BF mass and 1.5% for
total %BF. All scans were made in the morning after an
overnight 12-h fast. Quality control with spine phantom
was made every morning, and with step phantom every
week. By default, DXA software (QDR, version 12.4; Holo-
gic Inc., Marlborough, MA, USA) estimates the head,
trunk, arms and legs, both left and right, and region BC,
according to a three-compartment model (fat mass, lean
tissue and bone mass). The trunk region of interest (ROI)
(CV = 0.5%) includes chest, abdomen and pelvis regions
from the scan (21). All scans analysis were made by the
same observer. All scans were submitted to additional
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analysis by ROI to assess fat content of the abdominal
and central abdominal regions (CV = 1.0%) (21). The
upper and lower limits of the abdominal and central
abdominal ROI were determined as the upper edge of the
second lumbar vertebra to the lower edge of the fourth
lumbar vertebra, respectively (22–24). The lateral limits of
the abdominal ROI were determined to include all trunk
length but to exclude any upper limb scan area (23,24),
whereas the lateral sides of central abdominal ROI were
the vertical continuation of the lateral sides of the ribs
cage to exclude lateral subcutaneous fat of the trunk,
although including anterior and posterior subcutaneous
abdominal fat, as well as intra-abdominal fat (22) (Fig. 1).
Absolute and relative BF content results were registered
to the nearest 0.01 kg and 0.1%, respectively.
Anthropometric measurements consisted of weight,
height and BMI, as well as WC and WHtR. Some
standardisation procedures were taken into account, as
recommended previously (25), to avoid any bias in the
measurements; therefore, all WC measurements were
made with subjects in a standing comfortable position, in
their underwear, in a 12-h fasting state. All WC measure-
ments were made by the same technician, who was a
trained level 2 technician, certified by the International
Society for the Advancement of Kinanthropometry, using
an inelastic flexible metallic tape (W606PM; Lufkin, Van-
couver, BC, Canada) parallel to the floor after a tidal
exhalation, to the nearest 0.1 cm. The WC measurement
sites in the present study were the narrowest torso (WC1)
(26,27), also called minimal waist (19), superior border of
the iliac crest (WC2) (18,28), midpoint between the lowest
rib and iliac crest (WC3) (29) and umbilicus (WC4) (1,2).
These are the most commonly used protocols endorsed
by sound authorities in this field (17,19). Body weight was
measured to the nearest 0.1 kg, and height was measured
to the nearest 0.1 cm, on a scale with an attached sta-
diometer (model 770; Seca, Hamburg, Germany), in
accordance with a standard protocol (30). Both weight
and height were used to calculate the subjects’ BMI
(kg m–2]. WHtR was calculated by dividing each WC by
the subjects’ height [WHtR = WC (cm)/height (cm)].
Because we used four different WCmp for each subject,
we calculated four different WHtR using each measured
WC. Therefore, WHtR1, WHtR2, WHtR3 and WHtR4
were calculated using WC1, WC2, WC3 and WC4,
respectively. We considered a boundary value of 0.5 for
the identification of high WHtR (9,31). All anthropometric
measurements were repeated two times and, if the second
differed by more than 1 cm (for waist and height mea-
surements) or 0.5 kg (for weight measurement) from the
first measurement, a third measurement was carried out.
We always considered the result obtained in the second
measurement unless a third measurement was carried
out. When a third measurement was taken, we considered
the mode or, if mode was absent, the median value of all
three measurements. By use of this procedure, we aimed
to always use the most suitable value that was actually
measured on the subjects (instead of mean values).
Statistical analysis
Descriptive statistics are presented as the mean (SD)
and range for all analysed variables. The Gaussian dis-
tribution of the data was assessed with the Shapiro–
Wilk goodness-of-fit test. A paired samples t-test was
used to compare different WHtR. The association of all
WHtR with DXA measures was assessed using partial
and semipartial correlations (32), controlling for age, sex
and BMI. A statistical power of 80% (b = 0.20) at a
significance level of 5% (a = 0.05) was considered
Figure 1 Image of a dual energy X-ray absorptiometry scan showing
the abdominal region of interest (R2), defined as the area within the
upper edge of the second lumbar vertebra, and the lower edge of
the fourth lumbar vertebra and central abdominal region of interest
(R1), defined as R2 but the vertical sides limited to the continuation
of the lateral sides of the ribs cage.
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statistically significant. Consequently, only coefficients of
correlation equal or superior to 0.5, corresponding to a
large effect size, attained this criteria (P ≤ 0.05 and
b ≤ 0.20) and could be considered significant [this was
in accordance with Cohen et al. (1983) to ensure that
results are unexposed to type I and II errors, despite a
rather modest sample size]. Pairs of coefficients of cor-
relation obtained using different WHtR for each DXA
measure were compared using a Z-statistic to determine
whether any WHtR, according to the WC used in its
calculation, was more strongly associated with whole
and central BF. Statistical calculations were performed
using IBM SPSS, version 19 (IBM Corp., Armonk, NY,
USA), except for the Z-statistic, which was calculated
using MEDCALC, version 11.1.1.0 (MedCalc Software,
Mariakerke, Belgium).
Results
Mean values for all the studied variables are presented in
Table 1. From among the 28 studied NAFLD patients,
WHtR above the boundary value of 0.5 was present in
almost 100% of the sample, depending on the WCmp
used. Results for WC measurements were considered to
be different between all studied WCmp
(WC4 > WC2 > WC3 > WC1) and the magnitudes of
WHtR mean values were also different according to the
WC used. Obesity was present in nine subjects (three
were female), according to BMI classification, with no
differences between sexes in mean BMI (P = 0.075 via an
independent samples t-test).
Table 2 shows the results for partial and semipartial
correlations between each WHtR and each whole or
Table 1 Descriptive data fpr the study sample
Variables
NAFLD patients (n = 28)
Mean (SD) Minimum – Maximum
Age, year (median, year) 49.5 (12.8) (49) 25–68
Sex, n, female (% female) 9 (32.1)
VO2 max (mL kg
–1 min–1) 24.9 (6.4) 13.8–38.0
Type 2 diabetes mellitus, n (%) 8 (28.6)
Insulin resistance, n (%) 12 (42.9)
Anthropometry
Weight (kg) (CV, %) 87.6 (12.7) (0.07) 66.2–115.8
Height (cm) (CV, %) 167.2 (9.2) (0.03) 149.5–183.7
BMI (kg m–2) (% obese) 29.1 (4.0) (32.1) 22.6–42.2
WC 1 (cm) (CV, %) 100.7 (8.2)‡ (0.45) 86.0–119.8
WC 2 (cm) (CV, %) 104.8 (10.6)‡ (0.49) 85.3–128.7
WC 3 (cm) (CV, %) 103.7 (10.4)‡ (0.47) 85.7–129.3
WC 4 (cm) (CV, %) 106.3 (11.7)‡ (0.73) 86.7–129.1
WHtR 1 (≥0.5, %) 0.60 (0.07)† (96.4) 0.48–0.75
WHtR 2 (≥0.5, %) 0.63 (0.08)† (100.0) 0.50–0.82
WHtR 3 (≥0.5, %) 0.62 (0.08)† (96.4) 0.49–0.81
WHtR 4 (≥0.5, %) 0.64 (0.09)† (100.0) 0.50–0.85
Whole and regional body composition
BF (kg) (%) 27.2 (9.3) [31.31 (8.20)] 13.7–51.2 (18.84–46.28)
FFM (kg) (%) 58.7 (9.1) [68.69 (8.20)] 39.6–77.7 (53.72–81.16)
Trunk BF (kg) (%) 15.2 (5.2) [33.15 (7.65)] 7.4–25.0 (20.87–48.01)
Trunk FFM (kg) (%) 29.9 (3.9) [66.85 (7.65)] 21.1–38.6 (51.99–79.13)
Appendicular BF (kg) (%) 10.8 (4.8) [30.42 (10.39)] 5.2–25.7 (13.63–50.40)
Appendicular FFM (kg) (%) 24.5 (5.1) [69.58 (10.39)] 14.9–34.8 (49.60–86.37)
Abdominal BF (kg) (%) 3.5 (1.2) [37.57 (6.59)] 1.7–6.3 (26.09–49.40)
Central abdominal BF (kg) (%) 2.9 (0.8) [35.82 (5.70)] 1.6–5.0 (24.28–44.64)
BF, body fat; BF, body fat; BMI, body mass index; CV, coefficient of variation; FFM, fat free mass; FFM, fat free mass; HRR1, heart rate recovery
at 1 min; HRR2, heart rate recovery at 2 min.; Max., highest observed value; Min., lowest observed value; WC1, waist circumference measured at
narrowest torso; WC2, waist circumference measured at iliac crest; WC3, waist circumference measured at midpoint between lowest rib and iliac
crest; WC4, waist circumference measured at the umbilicus; WHtR 1, waist-to-height ratio calculated using waist circumference measured at nar-
rowest torso; WHtR 2, waist-to-height ratio calculated using waist circumference measured at iliac crest; WHtR 3, waist-to-height ratio calculated
using waist circumference measured at midpoint between lowest rib and iliac crest; WHtR 4, waist-to-height ratio calculated using waist circum-
ference measured at the umbilicus.
Results are presented as the mean (SD), unless otherwise noted.
†Different from all other WHtR mean values. P < 0.05 in paired samples t-test.
‡Different from all other WC mean values. P < 0.05 in paired samples t-test.
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central studied BF depot, controlling for sex, age and
BMI. All WHtR were correlated with the studied BF
depots, even after adjusting for age, sex and BMI, show-
ing coefficients of correlation magnitudes above 0.5.
Coefficients of correlation tended to decrease as control
variables were added, particularly when the effect of age,
sex and BMI was removed; however, the strength of asso-
ciation remained for abdominal fat depots.
Table 3 shows the results for the comparison (P-values)
between pairs of competing WHtR coefficients of correla-
tion with each dependent variable, as listed in Table 2.
No differences were found between all compared coeffi-
cients of correlation.
Discussion
To our knowledge, this is the first report to focus on the
strength of correlation between WHtR and BF in NAFLD
patients, as well as its variation associated with the differ-
ent WCmp used to calculate WHtR. Mean WHtR was
reasonably high and the prevalence of elevated WHtR,
considering the 0.5 boundary value, was very high in the
present sample. This was expected because NAFLD
patients have high values of WHtR (9,10). The magnitudes
of the WHtR mean values were different according to the
WC (WHtR4 > WHtR2 > WHtR3 > WHtR1) used in its
calculus, meaning that they are not interchangeable. This
may have large implications in clinical practice and data
collection and in the interpretation in longitudinal assess-
ments (pre – post), as well as for between-group
comparisons. Several previous studies have reported WC
magnitudes (the changeable component of WHtR) to be
influenced by WCmp (33–35). It has been proposed that
current WC thresholds, generalised using WHO protocol
(at the midpoint between lowest rib and iliac crest), could
be applied to National Institutes of Health measurements
(at the superior border of the iliac crest) (19) because of
the small or absent differences, particularly in men, found
between measurements using these WCmp (34,35). As
noted, the present study does not confirm such inter-
changeability when absolute values were taken into
account. However, when a dichotomous approach was
applied based on the boundary value of 0.5, both WHtR1
and WHtR2 only misclassified one subject (3.6%) at ele-
vated risk compared to WHtR2 and WHtR4, which diag-
nosed 100% of the sample above the boundary value, and
may be considered as support for an interchangeable use
of the protocols for WHtR assessment.
In the present sample of NAFLD patients, as expected,
WHtR was highly associated with whole and central BF,
adjusted for age, sex and BMI. Correlation coefficient
magnitudes revealed a large effect size (r > 0.5) for cen-
tral BF depots. The association of WHtR with BC, partic-
ularly with central BF, has been reported in diverse
groups (7,8) but not in NAFLD patients until now. WHtR
was also shown to predict higher cardiometabolic risk
better than WC and BMI (5). The present study showed
consistent coefficients of correlation of WHtR and central
fat depots, even when BMI was added to age and sex as
control variables, meaning that WHtR explains the
Table 2 Partial and semipartial correlations between all studied waist-to-height ratios and body fat content variables
Variables Whole BF Trunk BF Abd BF C Abd BF Whole %BF Trunk %BF Abd %BF C Abd %BF
WHtR 1 † 0.49 0.63* 0.81* 0.72* 0.51* 0.56* 0.65* 0.63*
‡ 0.41 0.58* 0.80* 0.72* 0.45 0.51* 0.66* 0.63*
§ 0.22 0.38* 0.70* 0.69* 0.22 0.32 0.54* 0.55*
WHtR 2 † 0.61* 0.73* 0.82* 0.74* 0.56* 0.59* 0.61* 0.61*
‡ 0.48 0.64* 0.84* 0.77* 0.46 0.52* 0.66* 0.63*
§ 0.26 0.43 0.74* 0.74* 0.23 0.32 0.54* 0.55*
WHtR 3 † 0.60* 0.72* 0.83* 0.74* 0.55* 0.59* 0.62* 0.61*
‡ 0.48 0.64* 0.84* 0.76* 0.46 0.52* 0.66* 0.62*
§ 0.25 0.42 0.74* 0.73* 0.22 0.32 0.54* 0.54*
WHtR 4 † 0.59* 0.68* 0.76* 0.68* 0.51 0.53* 0.56* 0.57*
‡ 0.44 0.58* 0.78* 0.71* 0.42 0.45 0.62* 0.60*
§ 0.23 0.38 0.68* 0.67* 0.20 0.27 0.49 0.50*
Abd BF, Abdominal body fat; BF, body fat; C Abd BF, Central abdominal body fat; Trunk BF, Trunk body fat; WHtR 1, waist-to-height ratio calcu-
lated using waist circumference measured at narrowest torso; WHtR 2, waist-to-height ratio calculated using waist circumference measured at
iliac crest; WHtR 3, waist-to-height ratio calculated using waist circumference measured at midpoint between lowest rib and iliac crest; WHtR 4,
waist-to-height ratio calculated using waist circumference measured at the umbilicus.
*Significant for P < 0.05 and b = 0.20.
†Partial correlations between studied WHtR and dependent variables, controlled for age and sex.
‡Partial correlations between studied WHtR and dependent variables, controlled for age, sex and body mass index.
§Semipartial correlations between studied WHtR and dependent variables, adjusted for age, sex and body mass index.
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variation of abdominal fat far beyond BMI. This relation-
ship was already found in subjects without NAFLD,
although with no control variables included in the analy-
sis (15). This may explain the marginally lower correlation
coefficients found in the present study.
Comparisons between pairs of competing WHtR corre-
lation results with each dependent variable showed that
all studied WHtR are similarly associated with the anal-
ysed BF depots, irrespective of the WC used for its calcu-
lation. Previous studies have already shown no differences
in the association of WC alone, measured at different
sites, with BF depots (33,35). A recent review concluded
that the use of different WCmp does not change the well-
established relationships between WC and morbidity of
cardiovascular disease and diabetes, as well as cardiovas-
cular and all-cause mortality (19). However, because
WHtR have proven to be more sensitive in the prediction
of cardiovascular risk, the absence of an influence of
WCmp in risk prediction should be confirmed when WC
is used to calculate WHtR.
There are several strengths and limitations to the present
study. The WCmp investigated do not cover all the proto-
cols existent in the literature, although the focus was on
those most commonly employed and endorsed by promi-
nent institutions for use in the clinical setting (17–19). In
addition, the assessment method (DXA) used for BC, com-
prising a gold standard instrument for assessing BC in a
three-compartment model, is unable to determine visceral
adiposity independent of subcutaneous fat. However, there
is a strong correlation between abdominal fat estimated
from selected DXA ROI and visceral fat assessed by mag-
netic resonance imaging (23) and computed tomography
(36). Patients’ physical activity and diet were not assessed;
however, patients’ cardiorespiratory fitness was assessed,
which was low (Table 1), reinforcing the importance of the
study of cardiovascular risk related markers in this popula-
tion (37). Finally, we could not establish the usefulness of
WHtR for assessing changes in BF depots based on the pre-
sent results because we used a cross-sectional approach and
therefore no follow-up data are available.
The present study confirms the strong association
between WHtR and BF, especially for central BF, even after
controlling for age, sex and BMI, in NAFLD patients, sup-
porting WHtR as an independent central obesity index.
Moreover, the relationship between WHtR and both whole
and central BF was not altered by the choice of a particular
Table 3 Z-statistic P-values for the comparison between the coefficients of correlation obtained in partial and semipartial correlation between the
studied waist-to-height ratios and all dependent variables.
WHtR 1 WHtR 2 WHtR 3 WHtR 4
P* P† P* P† P* P† P* P†
0.98 0.99 0.99 1.00 0.89 0.93 %BF WHtR 1
0.99 0.99 0.97 0.98 0.76 0.86 Trunk %BF
1.00 1.00 1.00 1.00 0.81 0.80 Abd %BF
0.98 0.99 0.99 0.99 0.86 0.84 C Abd %BF
WHtR 2 BF 0.73 0.87 0.99 0.99 0.87 0.92 %BF WHtR 2
Trunk BF 0.72 0.86 0.98 0.99 0.75 0.85 Trunk %BF
Abd BF 0.66 0.80 0.99 1.00 0.80 0.80 Abd %BF
C Abd BF 0.71 0.74 0.97 0.98 0.84 0.83 C Abd %BF
WHtR3 BF 0.79 0.90 0.94 0.97 0.88 0.93 %BF WHtR 3
Trunk BF 0.74 0.87 0.98 0.99 0.73 0.84 Trunk %BF
Abd BF 0.65 0.79 0.98 0.99 0.81 0.81 Abd %BF
C Abd BF 0.74 0.78 0.96 0.96 0.87 0.85 C Abd %BF
WHtR4 BF 0.88 0.96 0.85 0.91 0.91 0.94
Trunk BF 0.98 0.98 0.70 0.84 0.72 0.85
Abd BF 0.72 0.87 0.54 0.68 0.52 0.67
C Abd BF 0.95 0.90 0.66 0.65 0.70 0.68
Abd BF, abdominal body fat; BF, body fat; C Abd BF, central abdominal body fat; trunk BF, Trunk body fat; WHtR 1, waist-to-height ratio calcu-
lated using waist circumference measured at minimal waist; WHtR 2, waist-to-height ratio calculated using waist circumference measured at iliac
crest; WHtR 3, waist-to-height ratio calculated using waist circumference measured at midpoint between lowest rib and iliac crest; WHtR 4,
waist-to-height ratio calculated using waist circumference measured at the umbilicus.
*Comparison between correlation coefficients obtained in partial correlations between different WHtR and all dependent variables, controlled for
age, sex and body mass index.
†Comparison between correlation coefficients obtained in semipartial correlations between different WHtR and all dependent variables, controlling
for age, sex and body mass index.See bottom-left half for comparisons between coefficients of correlation obtained between WHtRs and obsolute
values of body composition; see upper-right half for comparisons between coefficients of correlation obtained between WHtRs and relative values
of body composition.
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WCmp in the present sample of NAFLD patients. Unlike
previous studies in subjects without diagnosed NAFLD (15),
we could not recommend the use of one specific WC mea-
surement protocol over another for the calculation of
WHtR as a whole and/or central BF surrogate. Thus, the
results of the present study may endorse an interchangeable
use of different WCmp for identifying a subject’s WHtR
above the boundary value. Additional research is needed to
confirm the influence of different WCmp on the variation
of WHtR in specific subpopulations, as well as on the rela-
tionship between WHtR and other NAFLD and car-
diometabolic risk factors beyond BC alone.
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